Sage Therapeutics(SAGE) - 2023 Q3 - Earnings Call Presentation

2023 Financial Results • Forward-looking statements in this presentation include statements regarding: plans and goals for commercialization of ZURZUVAE as a treatment for women with PPD and expected timelines; our belief in the potential benefit and profile of ZURZUVAE in the treatment of PPD; our plans, goals, and expectations regarding access to ZURZUVAE for women with PPD and reimbursement; the potential for success of our other product candidates in various indications, including the potential profile ...